[HTML][HTML] Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

DT Hoang, KA Iczkowski, D Kilari, W See… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …

[PDF][PDF] Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

DT Hoang, KA Iczkowski, D Kilari, W See… - researchgate.net
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …

Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.

DT Hoang, KA Iczkowski, D Kilari, W See… - 2017 - jdc.jefferson.edu
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …

[HTML][HTML] Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

DT Hoang, KA Iczkowski, D Kilari, W See… - Oncotarget, 2016 - oncotarget.com
Androgen receptor-dependent and -independent mechanisms driving prostate cancer
progression: Opportunities for therapeutic targeting from multiple angles | Oncotarget Online …

Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

DT Hoang, KA Iczkowski, D Kilari, W See… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …

[PDF][PDF] Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.

DT Hoang, KA Iczkowski, D Kilari, W See… - core.ac.uk
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …

Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.

D Hoang, K Iczkowski, D Kilari, W See… - Oncotarget, 2017 - escholarship.org
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …

Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.

DT Hoang, KA Iczkowski, D Kilari, W See… - Oncotarget, 2017 - europepmc.org
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …

Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

DT Hoang, KA Iczkowski, D Kilari, W See… - Oncotarget, 2016 - oncotarget.com
Androgen receptor-dependent and -independent mechanisms driving prostate cancer
progression: Opportunities for therapeutic targeting from multiple angles | Oncotarget Online …

Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.

DT Hoang, KA Iczkowski, D Kilari, W See… - Oncotarget, 2017 - europepmc.org
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …